v3.26.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net earnings $ 697 $ 1,289
Foreign currency translation adjustments, net of tax expense (benefit) of $(5) for the three months ended March 31, 2026 and $17 for the three months ended March 31, 2025 (204) 487
Net investment hedging activities, net of tax expense (benefit) of $43 for the three months ended March 31, 2026 and $(77) for the three months ended March 31, 2025 156 (283)
Pension and post-employment benefits, net of tax expense (benefit) of $— for the three months ended March 31, 2026 and $— for the three months ended March 31, 2025 (1) (2)
Cash flow hedging activities, net of tax expense (benefit) of $— for the three months ended March 31, 2026 and $(4) for the three months ended March 31, 2025 40 (19)
Other comprehensive income (loss) (9) 183
Comprehensive income 688 1,472
Comprehensive income attributable to noncontrolling interest 2 3
Comprehensive income attributable to AbbVie Inc. $ 686 $ 1,469